Islet cell antibody frequency differs from that of glutamic acid decarboxylase antibodies/IA2 antibodies after diagnosis of diabetes

Acta Paediatrica, International Journal of Paediatrics

Volumn 89, Issue 1, 2000, Pages 46-51

  Borg, H ^a,c   Marcus, C ^b   Sjoblad S ^a   Fernlund, P ^a   Sundkvist, G ^a  

^a LUND UNIVERSITY   (Sweden)

^b STOCKHOLM UNIVERSITY   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Autoantibodies; Glutamic acid decarboxylase 65; Islet cell antibodies; Type 1 diabetes; Tyrosine phosphatase

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE; PANCREAS ISLET CELL ANTIBODY; RADIOLIGAND;

ADOLESCENT; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNITY; CHILD; DISEASE MARKER; FOLLOW UP; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIGAND BINDING; PRIORITY JOURNAL;

EID: 0033958107     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2000.tb01186.x     Document Type: Article

References (27)

1. 1. Landin-Olsson M, Palmer JP, Lernmark Å, Blom L, Sundkvist G, Nyström L, et al. Predictive value of islet cell and insulin autoantibodies for Type 1 (insulin-dependent) diabetes mellitus in a population-based study of newly-diagnosed diabetic and matched control children. Diabetologia 1992; 35: 1068-73
2. 2. Bækkeskov S, Jan-Aanstoot H, Christgau S, Reetz A, Solimena M, Cascalho M, et al. Identification of the 64K autoantigen in insulin dependent diabetes as the GABA synthesizing enzyme glutamate decarboxylase. Nature 1990; 347: 151-6
3. 35S]GAD 65-ligand binding assay. Clin Chem 1997; 43: 779-85
4. 4. Payton MA, Hawkes CJ, Christie MR. Relationship of the 37,000-and 40,000-Mr tryptic fragments of the islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA2 (ICA512). J Clin Invest 1995; 96: 1506-11
5. 5. Bonifacio E, Lampasona V, Genovese S, Ferrari M, Bosi E. Identification of protein tyrosine phosphatase-like insulin dependent-related 37/40K autoantigen and a target for islet-cell antibodies. J Immunol 1995; 155: 5419-26
6. 6. Borg H, Fernlund P, Sundkvist G. Protein tyrosine phosphatase-like protein IA2-antibodies plus glutamic acid decarboxylase 65 antibodies (GADA) indicates autoimmunity as frequently as islet cell antibodies assay in children with recently diagnosed diabetes mellitus. Clin Chem 1997; 43: 2358-63
7. 7. Atkinson MA, Kaufman DL, Newman D, Tobin AJ, Maclaren NK. Islet cell cytoplasmic antibody reactivity to glutamate decarboxylase in insulin-dependent diabetes. J Clin Invest 1993; 91: 350-6
8. 8. Seissler J, Morgenthaler NG, Achenbach P, Lampeter EF, Glawe D, Payton M, et al. Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM. Diabetologia 1996; 39: 1351-6
9. 9. Gorus FK, Goubert P, Semakula C, Vandewalle CL, De Schepper J, Scheen A, et al. IA-2-autoantibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings. Diabetologia 1997; 40: 95-9
10. 10. Kawasaki E, Moriuchi R, Takimo H, Okuno S, Takao Y, Maeda Y, et al. Autoantibodies to 64,000-Mr islet cell protein in long term Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1992; 35: 748-52
11. 11. Muhr D, Mollenhauer U, Ziegler AG, Haslbeck M, Standl E, Schnell O. Autoantibodies to sympathetic ganglia, GAD, or tyrosine phosphatase in long-term IDDM with and without ECG-based cardiac autonomic neuropathy. Diabetes Care 1997; 20: 1009-12
12. 12. Yokota I, Matsuda J, Naito E, Ito M, Shima K, Kuroda Y. Comparison of GAD and ICA512/IA-2 antibodies at and after the onset of IDDM. Diabetes Care 1998; 21: 49-52
13. 13. Landin-Olsson M, Sundkvist G, Lernmark Å. Prolonged incubation in the two-colour immunofluorescence test increases the prevalence and titres of islet cell antibodies in Type I (insulin-dependent) diabetes mellitus. Diabetologia 1987; 30: 327-32
14. 14. Heding L. Radioimmunological determination of human C-peptide in serum. Diabetologia 1975; 11: 541-8
15. 15. Gottsäter A. Ability of beta cell function tests and autoimmune markers to clarify the type of diabetes in adult patients. Department of medicine. Malmö: Lund University, 1994: 140
16. 16. Hermitte L, Atlan-Gepner C, Mattei C, Dufayet D, Jannot M, Christofilis M, et al. Diverging evolution of anti-GAD and anti-IA-2 antibodies in long-standing diabetes mellitus as a function of age at onset: no association with complications. Diabet Med 1998; 15:586-91
17. 17. Sundkvist G, Velloso LA, Kämpe O, Rabinowe SL, Ivarsson SA, Lilja B, et al. Glutamic acid decarboxylase antibodies, autonomic nerve antibodies and autonomic neuropathy in diabetic patients. Diabetologia 1994; 37: 293-9
18. 18. Zanone MM, Petersen JS, Peakman M, Mathias CJ, Watkins PJ, Dyrberg T, et al. High prevalence of autoantibodies to glutamic acid decarboxylase in long-standing IDDM is not a marker of symtomatic autonomic neuropathy. Diabetes 1994; 43: 1146-51
19. 19. Savola K, Sabbah E, Kulmala P, Vahasalo P, Ilonen J, Knip M. Autoantibodies associated with Type I diabetes mellitus persist after diagnosis in children. Diabetologia 1998; 41: 1293-7
20. 20. Bonfanti R, Bazzigaluppi E, Calori G, Riva M, Viscardi M, Bognetti E, et al. Parameters associated with residual insulin secretion during the first year of disease in children and adolescents with Type I diabetes mellitus. Diabet Med 1998; 15: 844-50
21. 21. Wiest-Ladenburger U, Hartmann R, Hartmann U, Berling K, Böhm O, Richter W. Combined analysis and single-step detection of GAD65 and IA2 autoanitbodies in IDDM can replace the histochemical islet cell antibody test. Diabetes 1997; 46: 565-71
22. 22. Hawa M, Rowe R, Lan MS, Notkins AL, Pozzilli P, Christie MR, et al. Value of antibodies to islet protein phosphatase-like molecule in predicting Type 1 diabetes. Diabetes 1997; 46: 1270-5
23. 23. Bingley PJ, Bonifacio E, Williams AJK, Genovese S, Bottazzo GF, Gale EAM. Prediction of IDDM in the general population. Strategies based on combinations of autoantibody markers. Diabetes 1997; 46: 1701-10
24. 24. Savola K, Bonifacio E, Sabbah E, Kulmala P, Vahasalo P, Karjalainen J, et al. IA-2 antibodies - a sensitive marker of IDDM with clinical onset in childhood and adolescence. Diabetologia 1998; 41: 424-9
25. 25. Myers AM, Rabin DU, Rowley MJ. Pancreatic islet cell cytoplasmic antibody in diabetes is represented by antibodies to islet cell antigen 512 and glutamic acid decarboxylase. Diabetes 1995; 44: 1290-5
26. 26. Augstein P, Schlosser M, Ziegler B, Hahmann J, Mauch L, Ziegler M. Comparison of the islet cell antibody pattern of monoclonal glutamic acid decarboxylase antibodies recognizing linear and conformational epitopes. Acta Histochem 1996; 98: 229-41
27. 27. Söhnlein P, Müller M, Syren K, Åkerblom H, Knip M, Richter W. Evidence for immunoglobulin epitope spreading in GAD65 during the prediabetic period of type 1 diabetes. Diabetologia 1998; 41 Suppl 1: A12